Restraint of Powassan virus replication by TRIM5a facilitates viral avoidance of antiviral immunity

We previously reported that TRIM5a derived from humans and rhesus macaques inhibits replication of orthoflaviviruses belonging to the tick-borne encephalitis virus (TBEV) serocomplex, including TBEV, Kyasanur forest disease virus and Langat virus (LGTV), but interestingly not the tick-borne Powassan virus (POWV).

To further characterize the primate TRIM5a and orthoflavivirus interface, we screened TRIM5a variants from representative old- and new-world primates for restriction capacity. TRIM5a from old-world African green monkey, De Brazza’s monkey and chimpanzee demonstrated virus-specific restriction of tick-borne orthoflaviviruses. Efforts to determine why TRIM5a fails to inhibit POWV revealed that our lab stock had acquired a non-synonymous mutation in NS3 that, when introduced into a POWV molecular clone, facilitated virus replication in the presence of all inhibitory primate TRIM5a proteins.